Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.36
-0.09 (-1.40%)
At close: Nov 20, 2024, 4:00 PM
6.33
-0.03 (-0.47%)
After-hours: Nov 20, 2024, 7:54 PM EST
Ginkgo Bioworks Holdings Stock Forecast
DNA's stock price has decreased by -89.54% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for DNA stock have an average target of 37.8, with a low estimate of 7.00 and a high estimate of 120. The average target predicts an increase of 494.34% from the current stock price of 6.36.
Analyst Consensus: Hold
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for DNA stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Total | 6 | 6 | 6 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | +57.23% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | +10.06% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | +88.68% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | +25.79% | Jun 26, 2024 |
| BTIG | BTIG | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | May 15, 2024 |
Financial Forecast
Revenue This Year
187.37M
from 251.46M
Decreased by -25.49%
Revenue Next Year
211.44M
from 187.37M
Increased by 12.85%
EPS This Year
-12.84
from -18.40
EPS Next Year
-8.05
from -12.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 199.5M | 241.5M | 306.8M | |
| Avg | 187.4M | 211.4M | 260.8M | |
| Low | 174.1M | 181.3M | 200.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -20.7% | 28.9% | 45.1% | |
| Avg | -25.5% | 12.8% | 23.4% | |
| Low | -30.8% | -3.2% | -5.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -12.60 | -7.48 | -4.48 | |
| Avg | -12.84 | -8.05 | -6.06 | |
| Low | -12.94 | -9.00 | -8.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.